The report notes Hyundai Motor India recorded its highest-ever monthly sales in September at 77,916 units, up 10.8% YoY.
Read this note →Research notes
What India's research desks published, reported with attribution and linked to the original notes. Orivam issues no recommendations of its own.
1793 notes · 01 Oct 2026, 00:00 to 01 Nov 2026, 00:00 IST
The note says it estimates a ~7% EBITDA impact for Aster DM and maintains BUY.
Read this note →The note says it estimates a ~6% EBITDA impact for Max Healthcare and maintains BUY.
Read this note →The note says it estimates a ~5% EBITDA impact for Apollo Hospital under the assumed margin-cap scenario and maintains a BUY rating.
Read this note →The report highlights Leela Palaces Hotels & Resorts on technical radar, noting more momentum above 586 with support at 555 on strong bullish candle and robust volumes.
Read this note →The report flags an ONGC futures SELL trade for 27th Oct, citing a consolidation breakdown and overall downtrend with resistance at 233.
Read this note →The report gives a technical conviction delivery BUY call on Syrma SGS Technology at CMP ₹1783 with SL ₹1728 and target ₹1893, citing a Pole and Flag breakout and RSI bullish crossover; it also appears in the Focus Investment Ideas table with target Rs 2,000.
Read this note →The report lists Emcure Pharma as a Focus Investment Idea with a Buy rating, CMP Rs 1,943 and target Rs 2,300, implying 18% upside.
Read this note →The report lists Adani Ports as a Focus Investment Idea with a Buy rating, CMP Rs 1,798 and target Rs 2,130, implying 18% upside.
Read this note →The report lists SPR Auto Technologies as a Focus Investment Idea with a Buy rating, CMP Rs 4,654 and target Rs 6,150, implying 32% upside.
Read this note →The report lists Eternal as a Focus Investment Idea with a Buy rating, CMP Rs 320 and target Rs 430, implying 34% upside over a 1-year horizon.
Read this note →The report recommends BUY on Divis Laboratories at CMP ₹9,540 with target ₹10,800 and stop-loss ₹8,870, citing peptide API demand growth, favorable US tariff clarity, and expected 21% earnings CAGR over FY26-28.
Read this note →The report rates GE Vernova T&D India BUY with CMP INR 4,201 and target INR 5,100, citing India's transmission investment cycle, order book above Rs 300bn, and expected revenue/EBITDA/PAT CAGR of 26%/24%/24% over FY26-29E.
Read this note →The report rates LG Electronics India BUY with CMP INR 1,711 and target INR 2,080, citing double-digit growth across TV, washing machine and AC categories, an AC price hike, premiumization and Sri City capacity expansion.
Read this note →The report states Bluedart Express is set to increase prices by 9-12% effective January 2027, viewed positively.
Read this note →The report notes Aurobindo Pharma's subsidiary Acrotech Biopharma launched ADQUEY ointment in the US, marking its entry into US dermatology market, viewed positively.
Read this note →The report states ACC has commissioned a 2.4 MTPA grinding unit in Uttar Pradesh and added 1 MTPA blending capacity in Maharashtra, taking combined capacity to 3.4 MTPA, viewed positively.
Read this note →The report notes L&T's Transportation Infrastructure vertical secured twin contracts worth Rs 30,000 cr from Dubai's RTA and views this positively.
Read this note →